Nektar Therapeutics | NKTR - Capital Ordinário





Capital Ordinário Alterar Data
Agios Pharmaceuticals USD 59.34M 892K 2026-03
ALKERMES USD 167.54M 1.08M 2026-06
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 541M 1000K 2026-06
Baxter International USD 517M 549K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cara Therapeutics USD 9.38M 2.01K 2026-03
Cipla INR 807.78M 17K 2026-03
Dr.Reddys Laboratories INR 832.69M 176K 2026-03
Eisai JPY 282.46M 345K 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 248.88M 4.82M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 114.04M 4.48M 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.56M 241K 2026-03
Merck USD 2.47B 4.93M 2026-03
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Neurocrine Biosciences USD 100.55M 50K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
Takeda JPY 1.58B 460K 2026-06
Teva Pharmaceutical Industries USD 1.16B 1000K 2026-06
Xencor USD 74.33M 265K 2026-06